Week 48 results from a randomized clinical trial of rilpivirine/emtricitabine/tenofovir disoproxil fumarate vs. efavirenz/emtricitabine/tenofovir disoproxil fumarate in treatment-naive HIV-1-infected adults
暂无分享,去创建一个
K. White | J. van Lunzen | R. Ebrahimi | C. Cohen | D. Wohl | J. Arribas | M. Bloch | D. Porter | W. Towner | K. Henry | E. Wilkins | S. Chuck | T. Fralich | S. De‐oertel | I. Walker